Estrogenic Activity of Derris scandens Stem Extract and its Major Compounds Using MCF-7 Cell Proliferation Assay and Estrogen-Related Gene Expression.
| Autor: | Sae-Foo, Worapol, Yusakul, Gorawit, Nualkaew, Natsajee, Putalun, Waraporn |
|---|---|
| Předmět: |
ANTI-inflammatory agents
IN vitro studies PEARSON correlation (Statistics) RESEARCH funding DATA analysis PLANT stems ISOFLAVONES CELL proliferation HERBAL medicine POLYMERASE chain reaction PHYTOESTROGENS DESCRIPTIVE statistics ESTRADIOL PLANT extracts ESTROGEN receptors GENE expression CELL lines ANALGESICS MOLECULAR structure ONE-way analysis of variance STATISTICS DATA analysis software THAI medicine ANDROGEN receptors PHARMACODYNAMICS |
| Zdroj: | Planta Medica; Aug2024, Vol. 90 Issue 10, p766-773, 8p |
| Abstrakt: | Derris scandens , which contains isoflavones and prenylated derivatives, has analgesic and anti-inflammatory properties and is an ingredient in traditional Thai medicine for perimenopause and menopause. However, the estrogenic activity of D. scandens has not yet been explored. Therefore, this study aimed to examine the estrogenic activity of the stem extract of D. scandens and its isoflavone derivatives. In this study, we conducted a proliferation assay in MCF-7 cells, and used quantitative reverse transcription polymerase chain reaction to assess gene expression. We found that the relative cell proliferation of the compounds (1 µM) was ranked in the following order as compared to 0.1 nM 17 β -estradiol (100%): genistein (97.84%) > derrisisoflavone A (83.17%) > genistein-7- O -[ α -rhamnopyranosyl-(1 → 6)-glucopyranoside] (69.55%) > 6,8-diprenylgenistein (51.91%) > lupalbigenin (18.72%). Furthermore, cotreatment with 1 µM lupalbigenin and 0.1 nM 17 β -estradiol was performed, which decreased cell proliferation to 80.38%. In vitro results suggest that lupalbigenin has an estrogen-antagonistic effect. At a dose of 1 µM, genistein had the strongest efficacy in increasing the expression of human estrogen receptor β by 4.0-fold compared to the control. Furthermore, genistein-7- O -[ α -rhamnopyranosyl-(1 → 6)]- β -glucopyranoside augmented the gene expression of human estrogen receptor α and human estrogen receptor β by 1.5- and 3.4-fold, respectively. Prenylated derivatives of genistein (derrisisoflavone A, 6,8-diprenylgenistein, and lupalbigenin) significantly suppressed the gene expression of the human androgen receptor. The administration of the crude extract at 10 µg/mL significantly suppressed human androgen receptor (0.6-fold) and transmembrane protease serine 2 (0.1-fold) expression but did not significantly affect human estrogen receptor α and human estrogen receptor β gene expression. This herbal medicine may be safe for estrogen-exposed breast cancer patients. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|